TW407146B - 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives having infibition activity to kynurenine-3-hydroxylase enzyme - Google Patents
2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives having infibition activity to kynurenine-3-hydroxylase enzyme Download PDFInfo
- Publication number
- TW407146B TW407146B TW087102847A TW87102847A TW407146B TW 407146 B TW407146 B TW 407146B TW 087102847 A TW087102847 A TW 087102847A TW 87102847 A TW87102847 A TW 87102847A TW 407146 B TW407146 B TW 407146B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- hydrogen
- cyclopropane
- formula
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/18—Saturated compounds containing keto groups
- C07C62/20—Saturated compounds containing keto groups with a saturated six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/38—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9705031.4A GB9705031D0 (en) | 1997-03-11 | 1997-03-11 | 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
TW407146B true TW407146B (en) | 2000-10-01 |
Family
ID=10809053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW087102847A TW407146B (en) | 1997-03-11 | 1998-02-26 | 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives having infibition activity to kynurenine-3-hydroxylase enzyme |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0973720A1 (xx) |
JP (1) | JP2001514634A (xx) |
KR (1) | KR20000076096A (xx) |
CN (1) | CN1252049A (xx) |
AU (1) | AU6497998A (xx) |
CA (1) | CA2283184A1 (xx) |
EA (1) | EA199900809A1 (xx) |
GB (1) | GB9705031D0 (xx) |
HU (1) | HUP0001023A3 (xx) |
IL (1) | IL131676A0 (xx) |
NO (1) | NO994386L (xx) |
PL (1) | PL335601A1 (xx) |
TW (1) | TW407146B (xx) |
WO (1) | WO1998040344A1 (xx) |
ZA (1) | ZA981972B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1424333A1 (en) * | 2002-11-28 | 2004-06-02 | Newron Pharmaceuticals S.p.A. | Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
EP1475088A1 (en) * | 2003-05-05 | 2004-11-10 | Newron Pharmaceuticals S.p.A. | Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract |
EP1475385A1 (en) * | 2003-05-05 | 2004-11-10 | Newron Pharmaceuticals S.p.A. | Glycoside derivatives of 2-(3,4-dichlorobenzoyl)-cycopropane-1-carboxylic acid |
WO2013151707A1 (en) * | 2012-04-05 | 2013-10-10 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
CN103373911B (zh) * | 2012-04-27 | 2016-12-14 | 中国科学院上海有机化学研究所 | 单氟代环丙烷类化合物及其制备方法和应用 |
CN104119246A (zh) * | 2013-04-26 | 2014-10-29 | 中国科学院上海有机化学研究所 | 环丙烷衍生物及其制备方法和应用 |
WO2015047982A2 (en) | 2013-09-26 | 2015-04-02 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
JP6449893B2 (ja) * | 2013-09-26 | 2019-01-09 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | キヌレニン−3−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3655667A (en) * | 1968-04-04 | 1972-04-11 | Smith Kline French Lab | 1-(2-benzoylcyclopropylmethyl)-4-phenylpiperazines |
-
1997
- 1997-03-11 GB GBGB9705031.4A patent/GB9705031D0/en active Pending
-
1998
- 1998-02-16 CA CA002283184A patent/CA2283184A1/en not_active Abandoned
- 1998-02-16 EP EP98910685A patent/EP0973720A1/en not_active Withdrawn
- 1998-02-16 EA EA199900809A patent/EA199900809A1/ru unknown
- 1998-02-16 CN CN98804144A patent/CN1252049A/zh active Pending
- 1998-02-16 KR KR1019997008184A patent/KR20000076096A/ko not_active Application Discontinuation
- 1998-02-16 JP JP53912398A patent/JP2001514634A/ja not_active Withdrawn
- 1998-02-16 PL PL98335601A patent/PL335601A1/xx unknown
- 1998-02-16 HU HU0001023A patent/HUP0001023A3/hu unknown
- 1998-02-16 WO PCT/EP1998/000883 patent/WO1998040344A1/en not_active Application Discontinuation
- 1998-02-16 AU AU64979/98A patent/AU6497998A/en not_active Abandoned
- 1998-02-16 IL IL13167698A patent/IL131676A0/xx unknown
- 1998-02-26 TW TW087102847A patent/TW407146B/zh active
- 1998-03-09 ZA ZA981972A patent/ZA981972B/xx unknown
-
1999
- 1999-09-10 NO NO994386A patent/NO994386L/no unknown
Also Published As
Publication number | Publication date |
---|---|
KR20000076096A (ko) | 2000-12-26 |
AU6497998A (en) | 1998-09-29 |
EA199900809A1 (ru) | 2000-08-28 |
WO1998040344A1 (en) | 1998-09-17 |
JP2001514634A (ja) | 2001-09-11 |
IL131676A0 (en) | 2001-03-19 |
NO994386L (no) | 1999-11-02 |
HUP0001023A3 (en) | 2001-03-28 |
CA2283184A1 (en) | 1998-09-17 |
PL335601A1 (en) | 2000-05-08 |
GB9705031D0 (en) | 1997-04-30 |
ZA981972B (en) | 1998-09-09 |
CN1252049A (zh) | 2000-05-03 |
EP0973720A1 (en) | 2000-01-26 |
HUP0001023A2 (hu) | 2000-09-28 |
NO994386D0 (no) | 1999-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007270951B2 (en) | Dioxo-alkanes and dioxo-alkenes | |
US9399631B2 (en) | Polyphenol proteasome inhibitors, synthesis, and methods of use | |
JP2771328B2 (ja) | N―フェニルアルキル置換α―アミノカルボキシアミド誘導体およびその製造方法 | |
US20070088027A1 (en) | Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient | |
FR2713225A1 (fr) | N-pipéridino-3-pyrazolecarboxamide substitué. | |
JP2002514179A (ja) | マトリックスメタロプロテイナーゼの阻害剤としてのビフェニル酪酸およびその誘導体 | |
EP2571352A1 (en) | Selective hdac inhibitors | |
FR2794742A1 (fr) | Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant | |
TW201010974A (en) | Cycloalkyl amine derivatives | |
TW407146B (en) | 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives having infibition activity to kynurenine-3-hydroxylase enzyme | |
NZ564130A (en) | N-propargyl-1-aminoindan compounds useful for treating obesity | |
EP0094886B1 (en) | Aminoalkadiene derivative | |
JPH08502046A (ja) | 心臓血管系疾患に用いられるベンゼンアルカン酸 | |
US7122543B2 (en) | Substituted benzoic acid derivatives having NF-κB inhibiting action | |
FR2521992A1 (fr) | Nouveaux composes de pyridine utiles comme medicaments | |
WO2013091285A1 (zh) | 一种脲类化合物、制备方法及其用途 | |
US6133302A (en) | 5-(3-Phenyl-3-oxo-propyl)-1H-tetrazole derivatives | |
US5326785A (en) | Caffeic acid derivatives and pharmaceutical compositions containing the same | |
JP2011001309A (ja) | オキシインドール誘導体及び神経細胞死抑制剤 | |
FR2795724A1 (fr) | Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant | |
US5973006A (en) | Fluoro-substituted benzoylpropionic acid derivatives | |
US20100286164A1 (en) | Substituted aryl alkylamino-oxy-analogs and uses thereof | |
AU2004266247A1 (en) | 1-carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof | |
KR101167036B1 (ko) | 신경 보호 효과에 탁월한 신규한 물질로 할로알킬 살리실 산 유도체와 이의 약학적으로 허용 가능한 염 및 이를 유효 성분으로 함유하는 뇌질환의 치료 및 예방용 약제학적 조성물 | |
HU212936B (en) | Process for producing (2r)-methyl-4,4,4-trifluorobutylamine |